Isle of Man based Chase Templeton Group Ltd has today announced their largest acquisition to date with the purchase of Bridgwater PMI specialist Preferred Medical Ltd for an undisclosed sum.

‘We are delighted to have secured such a high profile company into the Chase Templeton stable’ says Kevin Amphlett, Chairman of Chase Templeton Group ‘Phil Taylor and his team have forged an enviable reputation with clients and providers alike, winning many industry awards over the past few years. It is our intention to build on the strong foundations they have laid down. Phil has focussed on technology to drive his business forward and owning the rights to industry recognised systems such as the Prognosis quote engine was also a significant driver in making this purchase’ Phil Taylor will now join the board of Chase Templeton Ltd and also establish an Appointed Representative Company focussing on internet based PMI sales under the wings of Chase Templeton. Phil spoke of his excitement at the new opportunities before him “At Preferred Medical we have built a large PMI client base, but have never really been successful in developing that base into other product areas. We are looking forward to applying Chase Templeton’s skills in this area to further grow the business substantially’’.
Established in September 2002, Chase Templeton’s Growth has been impressive. The Groups PMI portfolio is now in excess of £30 million following the acquisition of Preferred Medical Ltd; Redferns insurance services, PHA ltd and Health Matters Ltd added to its own strong organic growth in this sector. The Group consists of Network Protect - the support Network for directly authorised PMI specialists; 1u ltd its product white labelling arm, Chase Templeton Mortgages with its 10 mortgage consultants and  Chase Templeton Ltd, its FSA regulated arm housing a salesforce of 75 independent Healthcare consultants and providing a  regulatory umbrella to 16 appointed representative companies.